Venous Thromboembolism (VTE) Clinical Trials

Find Venous Thromboembolism (VTE) Clinical Trials Near You

Thromboembolic Risk Assessment in Patients Admitted With Acute Medical Diseases to Conventional and At Home Hospitalization Units (TROMBODOM/ADOMFIB Study)

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

The thromboembolic disease is a common complication of patients admitted to conventional hospitalization units. To prevent such complications, thromboprophylaxis is indicated in high-risk patients identified with validated risk-assessment models such as Padua score and IMPROVE-VTE score. However, the relation between thromboembolic disease and inpatients is yet to be demonstrated in new clinical settings such as at home hospitalization units. Moreover, patient immobilization is key in the pathogenesis of thromboembolic complications: therefore, it is crucial to collect raw data of patient mobility during admission. The goal of this observational study is to compare the thromboembolic risk of patients admitted with acute medical diseases to at home hospitalization units with conventional hospitalization units. The main questions it aims to answer are: * Is the estimated thromboembolic risk of patients admitted with acute medical diseases to at home hospitalization units similar to those admitted to conventional hospitalization units? * Are the risk-assessment models used to predict thromboembolic risk of patients admitted with acute medical diseases to conventional hospitalization units (Padua and IMPROVE-VTE score) valid in at home hospitalization patients? Participants admitted with acute medical diseases to either a conventional hospitalization unit or at home hospitalization units will be included in a prospective registry in order to investigate the 90 days incidence of thromboembolic disease. A cohort of such patients will be controlled with triaxial accelerometer in order to collect raw data regarding patient mobility during admission.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥ 18 years

• Patients admitted with acute medical diseases to either a conventional hospitalization unit or at home hospitalization units

• Capable and willing to provide an informed consent

Locations
Other Locations
Spain
Hospital Universitario de Navarra
RECRUITING
Pamplona
Contact Information
Primary
Joao Modesto dos Santos, Medical Doctor
jmodestosantos@gmail.com
0034689208762
Time Frame
Start Date: 2023-03-01
Estimated Completion Date: 2025-03
Participants
Target number of participants: 1953
Treatments
At home hospitalization cohort
Participants admitted with acute medical diseases to at home hospitalization units will be included in a prospective registry in order to investigate the 90 days incidence of thromboembolic disease. A group of such patients will be controlled with triaxial accelerometer in order to collect raw data regarding patient mobility during admission.
Conventional hospitalization cohort
Participants admitted with acute medical diseases to a conventional hospitalization unit will be included in a prospective registry in order to investigate the 90 days incidence of thromboembolic disease. A group of such patients will be controlled with triaxial accelerometer in order to collect raw data regarding patient mobility during admission.
Sponsors
Collaborators: Daiichi Sankyo, Sociedad Española De Medicina Interna
Leads: Universidad Pública de Navarra

This content was sourced from clinicaltrials.gov